Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Overview of attention for article published in Journal of Neurology, September 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

blogs: 1 blog

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 65 Mendeley

Summary News Blogs Dimensions citations

So far, Altmetric has seen 1 news story.

No Conclusions About MS Drug Superiority

MedPage Today, 09 Oct 2015

Action Points Two prospective European cohort studies came to different conclusions about the relative efficacy of natalizumab (T…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.